Harbour makes $90M upfront deal with Bristol Myers for new antibodies
Harbour makes $90M upfront deal with Bristol Myers for new antibodies
Contenu indisponible. Consultez la source originale.
Harbour makes $90M upfront deal with Bristol Myers for new antibodies
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.